|
|
AI Applications in Global Pharmaceutical Regulatory Strategy and Operation
| ชื่อการประชุม |
 |
AI Applications in Global Pharmaceutical Regulatory Strategy and Operation |
| สถาบันหลัก |
 |
สมาคมเภสัชกรรมทะเบียนและกฎหมายผลิตภัณฑ์ (ประเทศไทย) |
| รหัสกิจกรรม |
 |
2006-2-000-003-07-2569 |
| สถานที่จัดการประชุม |
 |
To be Added |
| วันที่จัดการประชุม |
 |
09 ก.ค. 2569 |
| ผู้จัดการประชุม |
 |
สมาคมเภสัชกรรมทะเบียนและกฎหมายผลิตภัณฑ์ (ประเทศไทย) |
| กลุ่มเป้าหมาย |
 |
Pharmacists, Regulatory Affairs (RA) professionals, Digital Transformation specialists, Quality & Compliance managers, and Pharmaceutical/Biopharma industry leaders seeking to integrate advanced technology into global regulatory operations. |
| หน่วยกิตการศึกษาต่อเนื่อง |
 |
1.5 หน่วยกิต |
หลักการและเหตุผล
The landscape of the global pharmaceutical industry is undergoing a rapid paradigm shift, driven by exponential advancements in digital technologies and Artificial Intelligence (AI). In an increasingly complex global regulatory environment, pharmaceutical professionals and regulatory affairs specialists face the critical challenge of navigating diverse compliance frameworks, managing massive volumes of data, and accelerating lifecycle management to bring life-saving therapies to patients faster.
Traditionally, regulatory operations—ranging from intelligence gathering and submission strategy development to dossier compilation and compliance tracking—have been highly manual and time-consuming.
Today, AI-powered applications are emerging as disruptive tools that redefine these traditional workflows. From automating documentation and predicting health authority queries to streamlining smart compliance and transforming data into actionable regulatory intelligence, AI is no longer a futuristic concept but a strategic necessity.
As key stakeholders in the healthcare ecosystem, pharmacists, particularly those in regulatory affairs, clinical development, and quality compliance, must evolve alongside these technological shifts. Understanding how to responsibly and effectively leverage AI is essential to enhancing operational efficiency, minimizing regulatory risks, and maintaining a competitive edge in both regional and global markets.
วัตถุประสงค์
<>
This CPE session is designed to explore the transformative role of Artificial Intelligence in global pharmaceutical regulatory processes. Participants will gain practical insights into how multinational companies utilize AI to optimize submission strategies, accelerate dossier preparation, ensure digital regulatory compliance, and enhance data-driven decision-making throughout the product lifecycle.
<>
1. The Evolution of Digital Regulatory Affairs: Understanding the shift from traditional operational frameworks to AI-powered, digital regulatory environments.
2. Strategic AI Applications: Examining practical use cases where AI improves efficiency, accelerates health authority approvals, and manages complex regulatory submissions.
3. Smart Compliance & Lifecycle Management: Navigating the intersection of AI, data management, and strict regulatory compliance standards to maintain continuous market access.
วิธีสมัครการประชุม
To be Added
|